Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LAG-3
Pharma
Regeneron's Libtayo delivers lung cancer win with BMS' Yervoy
In this trial, Regeneron stopped the Libatyo-Yervoy-chemo arm early to focus on the sans-Yervoy regimen.
Angus Liu
Dec 1, 2022 12:25pm
ASCO: BMS offers closer look at Opdualag's LAG-3 melanoma win
May 26, 2022 5:00pm
BMS opens 3rd checkpoint inhibitor class
Mar 18, 2022 7:23pm